Notably, the anti-CXCR4 antibody used for immunohistochemistry binds to an intracellular epitope and therefore it is unlikely that low detection levels of CXCR4 expression in ADC 713-treated tumours are due to epitope masking by the anti-CXCR4 ADC. The gene discussed is CXCR4; the disease is neoplasm.